Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine for ultrasound-guided erector spinae plane block after posterior lumbar spinal surgery
ChiCTR2500100055Phase 4Not yet recruiting
- Sponsor
- Jingzhou Central Hospital
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by Jingzhou Central Hospital. Primary endpoints: VAS pain score 1 hour after surgery, VAS pain score 6 hours after surgery and 8 more. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500100055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100055.